Celecoxib-induced acute interstitial nephritis

Am J Kidney Dis. 2002 Jun;39(6):1313-7. doi: 10.1053/ajkd.2002.33412.

Abstract

Data about the nephrotoxicity of selective cyclooxygenase-2 inhibitors are still evolving. Acute interstitial nephritis is a well-described complication of therapy with nonselective nonsteroidal anti-inflammatory drugs. We report a case of biopsy-proven acute interstitial nephritis in a 73-year-old diabetic woman, who had taken celecoxib for more than 1 year before presentation. She presented with clinical findings of subnephrotic proteinuria and acute renal failure that required dialysis. She recovered renal function with cessation of celecoxib therapy after 2 weeks. Other medications were reintroduced safely, without recurrence of renal failure. A kidney biopsy specimen showed acute interstitial nephritis with a prominent eosinophilic infiltrate in the interstitium. This case documents the occurrence of acute interstitial nephritis with celecoxib and emphasizes the need for continued vigilance and care in use of cyclooxygenase-2 inhibitors in high-risk patients.

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / chemically induced
  • Acute Kidney Injury / pathology
  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Celecoxib
  • Cyclooxygenase Inhibitors / adverse effects*
  • Diabetes Mellitus, Type 2 / complications
  • Eosinophilia / pathology
  • Female
  • Humans
  • Nephritis, Interstitial / chemically induced*
  • Nephritis, Interstitial / pathology
  • Pyrazoles
  • Risk Factors
  • Sulfonamides / adverse effects*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase Inhibitors
  • Pyrazoles
  • Sulfonamides
  • Celecoxib